Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/186015
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lillo, Alejandro | - |
dc.contributor.author | Raïch, Iu | - |
dc.contributor.author | Lillo, Jaume | - |
dc.contributor.author | Pérez-Olives, Catalina | - |
dc.contributor.author | Navarro Brugal, Gemma | - |
dc.contributor.author | Franco Fernández, Rafael | - |
dc.date.accessioned | 2022-05-25T13:31:30Z | - |
dc.date.available | 2022-05-25T13:31:30Z | - |
dc.date.issued | 2022-01-19 | - |
dc.identifier.issn | 2227-9059 | - |
dc.identifier.uri | http://hdl.handle.net/2445/186015 | - |
dc.description.abstract | Adenosine (Ado) receptors have been instrumental in the detection of heteromers and other higher-order receptor structures, mainly via interactions with other cell surface G-protein-coupled receptors. Apart from the first report of the A1 Ado receptor interacting with the A2A Ado receptor, there has been more recent data on the possibility that every Ado receptor type, A1 , A2A, A2B, and A3 , may interact with each other. The aim of this paper was to look for the expression and function of the A2A/A3 receptor heteromer (A2AA3Het) in neurons and microglia. In situ proximity ligation assays (PLA), performed in primary cells, showed that A2AA3Het expression was markedly higher in striatal than in cortical and hippocampal neurons, whereas it was similar in resting and activated microglia. Signaling assays demonstrated that the effect of the A2AR agonist, PSB 777, was reduced in the presence of the A3R agonist, 2-Cl-IB-MECA, whereas the effect of the A3R agonist was potentiated by the A2AR antagonist, SCH 58261. Interestingly, the expression of the heteromer was markedly enhanced in microglia from the APPSw,Ind model of Alzheimer's disease. The functionality of the heteromer in primary microglia from APPSw,Ind mice was more similar to that found in resting microglia from control mice. | - |
dc.format.extent | 16 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/biomedicines10020214 | - |
dc.relation.ispartof | Biomedicines, 2022, vol. 10, num. 2, p. 1-16 | - |
dc.relation.uri | https://doi.org/10.3390/biomedicines10020214 | - |
dc.rights | cc-by (c) Lillo, Alejandro et al., 2022 | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.source | Articles publicats en revistes (Bioquímica i Biomedicina Molecular) | - |
dc.subject.classification | Malalties neurodegeneratives | - |
dc.subject.classification | Demència | - |
dc.subject.classification | Hipocamp (Cervell) | - |
dc.subject.classification | Escorça cerebral | - |
dc.subject.other | Neurodegenerative Diseases | - |
dc.subject.other | Dementia | - |
dc.subject.other | Hippocampus (Brain) | - |
dc.subject.other | Cerebral cortex | - |
dc.title | Expression of the Adenosine A2A-A3 Receptor Heteromer in Different Brain Regions and Marked Upregulation in the Microglia of the Transgenic APPSw,Ind Alzheimers Disease Model | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 721243 | - |
dc.date.updated | 2022-05-25T13:31:31Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Bioquímica i Biomedicina Molecular) Articles publicats en revistes (Bioquímica i Fisiologia) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
721243.pdf | 2.15 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License